billHR7920Event Thursday, March 12, 2026Analyzed

To amend title XVIII of the Social Security Act to prevent hospitals or skilled nursing facilities that are owned by certain firms from participating in the Medicare program.

Bearish
Impact5/10

Summary

HR7920 (Take Back Our Hospitals Act) proposes banning PE-owned hospitals and skilled nursing facilities from Medicare within 3 years. This early-stage bill (referred to two committees) has already correlated with -8% and -4.8% 30-day declines for HCA and UHS, while SNF-focused REITs like OHI, SBRA, and VTR have gained +6-7.5% in the same period, indicating the market has not yet priced in the downstream tenant risk for REITs. Passage probability is low given minority party sponsorship and early stage, but the bill's 10 cosponsors and identical Senate companion signal a growing legislative coalition that bears monitoring.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR7920 would ban PE-owned hospitals and SNFs from Medicare within 3 years — existential risk for any facility with PE links.
  • 2.The bill is early-stage with minority-party sponsorship; <10% passage probability in the 119th Congress given divided government.
  • 3.Market data shows a divergence: acute hospital operators (HCA, UHS) have declined -8% and -4.8% over 30 days, while SNF REITs (OHI, SBRA, VTR) have gained +6-7.5%, indicating the market is not yet pricing in the downstream tenant risk for REITs.
  • 4.If this bill gains a Republican co-sponsor or a committee hearing, expect significant repricing in SNF-exposed REITs.
  • 5.The 3-year phase-out provides a long transition period, but any facility with PE ownership or control today must begin restructuring.

Market Implications

The immediate market reaction has been muted for REITs but noticeable for operators. HCA at $435.45 (-7.99% in 30 days) and UHS at $170.37 (-4.81%) have already priced in some risk, possibly overestimating the bill's reach given that both are publicly traded, not PE-owned. The real structural risk lies downstream: OHI at $47.02, SBRA at $20.41, and VTR at $87.97 have all gained 6-7.5% in 30 days, driven by macro yield demand, not legislative awareness. If this bill progresses, expect a sharp reversal in REITs as the market connects tenant risk to REIT dividend coverage. ENSG at $187.37 (-7.01% in 30 days) has already declined, potentially reflecting its direct SNF operator exposure. For investors, the asymmetric risk is on the REIT side: bill stalls = no impact, bill advances = 15-20% downside in OHI and SBRA as tenants face Medicare disqualification. Monitor committee assignments and any Republican co-sponsor additions.

Full Analysis

HR7920, the 'Take Back Our Hospitals Act of 2026', was introduced on March 12, 2026 by Rep. Scanlon (D-PA) with 10 Democratic cosponsors. The bill would amend the Social Security Act to prohibit Medicare payments to hospitals or skilled nursing facilities 'owned or controlled by a covered firm or an affiliate of a covered firm'—defined broadly to include private equity firms and any entity that controls, is controlled by, or is under common control with a PE firm. Current facilities get a 3-year phase-out period. The bill has been referred to both Ways and Means and Energy and Commerce committees. An identical companion bill, S4085, has been introduced in the Senate and referred to Finance. The money trail here is straightforward: the mechanism is a statutory ban on payments, not a funding authorization. There are no taxpayer dollars appropriated by this bill—it works by denying existing Medicare funds to non-compliant facilities. For a typical hospital, Medicare accounts for 40-50% of revenue; for SNFs, it's often 60-80% of payer mix. The economic impact on affected facilities would be existential—they would either need to divest PE ownership within 3 years or lose the majority of their revenue. Structural winners and losers: The clearest winners under this bill are non-PE-owned operators. For-profit chains already free of PE ties (some HCA/UHS facilities, Community Health Systems) gain a competitive advantage as PE-owned rivals must restructure or exit. Publicly traded REITs with SNF exposure (OHI, SBRA, VTR) face a second-order risk: if their tenants are PE-affiliated and lose Medicare, those tenants cannot pay rent. However, REITs are not directly prohibited—only the operating facilities are. REITs could restructure by taking back facilities and finding non-PE operators. Ensign Group (ENSG), which operates SNFs directly, faces risk if any of its 300+ facilities have PE-linked minority stakes or management agreements that fall under the bill's broad 'control' definition. Real market data analysis: Over the 30 days since introduction, HCA dropped -7.99% (from ~$473 to $435), UHS dropped -4.81% (from ~$179 to $170). This suggests the market is pricing in some downside risk for the acute hospital operators, possibly overinterpreting the bill's reach. Meanwhile, SNF-focused REITs have actually gained: OHI +7.3% (to $47.02), SBRA +6.14% (to $20.41), VTR +7.56% (to $87.97), and NHC +7.81% (to $175.07). This divergence is striking—it suggests the market either (a) does not believe this bill will pass, (b) has not connected the tenant risk to REITs, or (c) is treating the REIT gains as a function of falling interest rates and yield demand. Given that the bill is early-stage with a minority-party sponsor, option (a) is most plausible. However, if this bill gains committee support or a GOP co-sponsor, expect significant repricing in REITs. The legislative timeline: the bill is at the very earliest stage (referred to committee). No hearings, markups, or votes have occurred. The 119th Congress runs through January 2027. For this bill to pass, it must clear Ways and Means and Energy and Commerce in the House, then Finance in the Senate, then survive a presidential veto. Given Democratic sponsorship in a divided government (Republican House majority, 53-47 Senate split, Republican president), passage in this Congress is highly unlikely. However, the 10 co-sponsors and identical companion bill indicate a growing coalition. If a Republican co-sponsor joins—particularly a healthcare-focused member like Rep. Brett Guthrie (R-KY, Chair of Energy and Commerce Health Subcommittee)—passage probability would increase. For now, this is a monitoring risk, not an active investing thesis.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$HCA▼ Bearish
Est. $28.0B revenue impact

What the bill does

statutory ban on Medicare payments to hospitals owned by private equity firms or their affiliates, with a 3-year phase-out for existing facilities

Who must act

hospitals and skilled nursing facilities owned or controlled by a covered firm (private equity) or affiliate

What happens

loss of Medicare reimbursement for any facility with remaining PE ownership after the 3-year transition period; facilities must divest PE ownership or lose ~40%+ of revenue from Medicare patients

Stock impact

HCA is publicly traded (not PE-owned), but the bill's broad 'affiliate' and 'control' definitions could ensnare management agreements or minority stakes held by PE-linked entities. HCA's ~42% of revenue from Medicare (~$28B annually) is at risk if any facility is deemed controlled by a PE affiliate. Near term, the 3-year exception provides time to restructure, but uncertainty around compliance is depressing the stock.

$$UHS▼ Bearish
Est. $3.0B revenue impact

What the bill does

statutory ban on Medicare payments to hospitals owned by private equity firms or their affiliates, with a 3-year phase-out for existing facilities

Who must act

hospitals and skilled nursing facilities owned or controlled by a covered firm (private equity) or affiliate

What happens

loss of Medicare reimbursement for any facility with remaining PE ownership after 3 years; Medicare is ~20% of UHS revenue (~$3B annually)

Stock impact

UHS is publicly traded and not PE-owned in its core acute care hospitals. However, its behavioral health facilities and some real estate joint ventures may involve PE partnerships that fall under 'affiliate' or 'control' definitions. The stock has declined -4.81% over 30 days as the market prices in risk, even though direct exposure is likely limited for most facilities.

Market Impact Score

5/10
Minimal ImpactModerateMajor Market Event

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.